US Patent 8536122 Acylated GLP-1 compounds
Patent 8536122 was granted and assigned to Novo Nordisk on September, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08536122 Acylated GLP-1 compounds US Patent 8536122 Acylated GLP-1 compounds
Infobox
Patent Number
085361220
Patent Number
85361220
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085361220
Date of Patent
September 17, 2013
0Patent Application Number
134122830
Date Filed
March 5, 2012
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08536122 Acylated GLP-1 compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08536122
Date of patent
September 17, 2013
Patent application number
13412283
Date Filed
March 5, 2012
Patent primary examiner
Find more entities like US Patent 8536122 Acylated GLP-1 compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.